New schizophrenia drug gets KFDA approval

Published: 2007-12-17 06:57:00
Updated: 2007-12-17 06:57:00
The Korea Food and Drug Administration (KFDA) has approved Janssen Korea's Invega (paliperidone) extended-release tablets for treatment of schizophrenia.

A similar medication, Risperdal (risperidone), has been available for some time. However, Invega is a new molecular entity containing an ac...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.